journal article·2025-03Open access

Photothermal Nanozyme‐Encapsulating Microneedles for Synergistic Treatment of Infected Wounds

Zesheng Chen, Lin Zhang, Ye Yang, Wenwen Cheng, Lingfeng Tu, Zijian Wang, Yun Chen, Weikang Hu

Advanced Functional Materials· Volume 35· Issue 12

Abstract

Abstract Photothermal therapy (PTT) is widely used in wound healing because it produces heat under near‐infrared irradiation, eliminating bacterial infections. However, excessive production of reactive oxygen species (ROS) occurs during PTT, which causes oxidative stress damage. In this study, a nanozyme, PDA‐MnO 2 (PM), is synthesized and encapsulated in the needle tip layer of a bi‐layer GelMA microneedle patch (PbMP), which has excellent mechanical properties and can easily penetrate the skin. In a study involving an SD rat wound model infected with S. aureus , the PbMP significantly accelerated the healing process of bacterially challenged wounds, resulting in better blood vessel growth, cell proliferation, and collagen biosynthesis than other wound dressings. The experiment shows that the PM nanoparticles in PbMP improve photothermal conversion efficiency and activate SOD and CAT, resulting in an efficient cascade enzyme reaction system to eliminate ROS during the PTT process. This study describes a highly effective nanozyme hydrogel microneedle platform with photothermal synergistic antibacterial effects on wound healing.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Wound Healing and Treatments · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Materials Science and Engineering Stem Cells and Tissue Engineering Manufacture Center Hubei University Wuhan 430062 China

Department of Urology Institute of Urology Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center Zhongnan Hospital of Wuhan University Wuhan 430071 China

Department of Biomedical Engineering Hubei Province Key Laboratory of Allergy and Immune Related Disease TaiKang Medical School (School of Basic Medical Sciences) Wuhan University Wuhan 430071 China

Funding

Fundamental Research Funds for the Central Universities

References (65)

Show source-provided references
1. Wang Z. · Adv. Mater. · 2023
2. 10.1038/s41570-021-00323-z10.1038/s41570-021-00323-z ↗
3. 10.3390/biom1212185210.3390/biom12121852 ↗
4. 10.1002/adma.20210684210.1002/adma.202106842 ↗
5. 10.1016/j.biomaterials.2023.12201510.1016/j.biomaterials.2023.122015 ↗
6. 10.1016/j.biomaterials.2024.12257110.1016/j.biomaterials.2024.122571 ↗
7. 10.1038/s41579-021-00649-x10.1038/s41579-021-00649-x ↗
8. 10.1002/adma.20220565310.1002/adma.202205653 ↗
9. 10.1002/adfm.20230113810.1002/adfm.202301138 ↗
10. 10.1002/adfm.20231427810.1002/adfm.202314278 ↗
11. 10.1002/EXP.2023006610.1002/EXP.20230066 ↗
12. 10.1002/adhm.20190013210.1002/adhm.201900132 ↗
13. 10.1002/EXP.2021008610.1002/EXP.20210086 ↗
14. 10.1038/s41467-024-45927-310.1038/s41467-024-45927-3 ↗
15. 10.1002/adma.20160489410.1002/adma.201604894 ↗
16. 10.1039/D3NA00903C10.1039/D3NA00903C ↗
17. 10.1016/j.cej.2023.14714810.1016/j.cej.2023.147148 ↗
18. 10.1002/smll.20230665610.1002/smll.202306656 ↗
19. 10.1021/acsnano.3c0316910.1021/acsnano.3c03169 ↗
20. 10.1038/s41467-023-35828-210.1038/s41467-023-35828-2 ↗
21. 10.1016/j.nantod.2023.10205910.1016/j.nantod.2023.102059 ↗
22. 10.1002/adhm.20230248510.1002/adhm.202302485 ↗
23. Huang J. · Adv. Healthcare Mater. · 2024
24. 10.1002/EXP.2021008910.1002/EXP.20210089 ↗
25. 10.1016/j.ijpharm.2022.12157810.1016/j.ijpharm.2022.121578 ↗
26. 10.1016/j.actbio.2024.08.03610.1016/j.actbio.2024.08.036 ↗
27. 10.1016/j.cej.2024.14893810.1016/j.cej.2024.148938 ↗
28. 10.1186/s40824-022-00275-510.1186/s40824-022-00275-5 ↗
29. 10.1002/adfm.20200017710.1002/adfm.202000177 ↗
30. 10.1038/s41467-022-32349-210.1038/s41467-022-32349-2 ↗
31. 10.1016/j.bioadv.2024.21388910.1016/j.bioadv.2024.213889 ↗
32. 10.1002/EXP.2021017010.1002/EXP.20210170 ↗
33. Wu C. · Acta Pharm. Sin. B · 2024
34. 10.1002/INMD.2023000810.1002/INMD.20230008 ↗
35. 10.1002/EXP.2021008310.1002/EXP.20210083 ↗
36. 10.1016/j.ijbiomac.2024.12996110.1016/j.ijbiomac.2024.129961 ↗
37. 10.1002/adhm.20230247010.1002/adhm.202302470 ↗
38. 10.1016/j.fmre.2023.05.00910.1016/j.fmre.2023.05.009 ↗
39. 10.1039/D0TB02490B10.1039/D0TB02490B ↗
40. 10.1016/j.colsurfa.2022.13071210.1016/j.colsurfa.2022.130712 ↗
41. 10.1039/D1BM00720C10.1039/D1BM00720C ↗
42. 10.1016/j.cej.2023.14526710.1016/j.cej.2023.145267 ↗
43. 10.1016/j.seppur.2022.12141210.1016/j.seppur.2022.121412 ↗
44. 10.1016/j.seppur.2022.12094310.1016/j.seppur.2022.120943 ↗
45. 10.1002/smll.20220011610.1002/smll.202200116 ↗
46. 10.1021/acsanm.3c0439210.1021/acsanm.3c04392 ↗
47. 10.1002/advs.20210601510.1002/advs.202106015 ↗
48. 10.1016/j.apsusc.2020.14837910.1016/j.apsusc.2020.148379 ↗
49. 10.1002/adhm.20230389210.1002/adhm.202303892 ↗
50. 10.1021/acsami.1c0043010.1021/acsami.1c00430 ↗
51. 10.1093/rb/rbad08710.1093/rb/rbad087 ↗
52. 10.3390/ma1201010410.3390/ma12010104 ↗
53. 10.1002/pat.459510.1002/pat.4595 ↗
54. 10.3390/ma1203050010.3390/ma12030500 ↗
55. 10.1016/j.cej.2024.15275910.1016/j.cej.2024.152759 ↗
56. 10.1016/j.cej.2023.14316010.1016/j.cej.2023.143160 ↗
57. 10.1002/adfm.20210991510.1002/adfm.202109915 ↗
58. 10.1016/j.cej.2023.14173210.1016/j.cej.2023.141732 ↗
59. 10.1016/j.biomaterials.2020.12061110.1016/j.biomaterials.2020.120611 ↗
60. 10.1016/j.cej.2020.12449410.1016/j.cej.2020.124494 ↗
61. 10.1016/j.carbpol.2023.12119310.1016/j.carbpol.2023.121193 ↗
62. 10.1039/D3BM00841J10.1039/D3BM00841J ↗
63. 10.1038/s41579-024-01035-z10.1038/s41579-024-01035-z ↗
64. 10.1016/j.cej.2024.14893810.1016/j.cej.2024.148938 ↗
65. 10.1002/adma.20210921310.1002/adma.202109213 ↗